Olmesartan Medoxomil in Diabetes Mellitus
NCT00185159
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
4449
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Cardiovascular Disease
Kidney Disease
Interventions
DRUG:
Olmesartan medoxomil
DRUG:
Placebo Tablets
Sponsor
Sankyo Pharma Gmbh